Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonvendi Pediatric Post-marketing Safety and Effectiveness Survey
jRCT2031250712Recruiting
- Sponsor
- Takeda
- Start
- Feb 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial of von Willebrand factor concentrate in von Willebrand disease (VWD), sponsored by Takeda. Primary endpoint: Number of participants with at least one adverse drug reaction. Started Feb 2026; status: recruiting.
02
Drugs
von Willebrand factor concentrate
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on jRCT2031250712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250712.